Provided By GlobeNewswire
Last update: Jul 17, 2024
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD)1 --
Read more at globenewswire.com